Recombinant Human GTPBP4 Protein, N-His from ProteoGenix; catalogue ARO-P12132; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Recombinant Human GTPBP4 Protein, also known as GTP-binding protein 4, is a member of the GTP-binding protein family. It is encoded by the GTPBP4 gene and is found in the cytoplasm of human cells. This protein plays a crucial role in regulating the activity of GTPases, which are enzymes involved in multiple cellular processes such as cell signaling, protein synthesis, and cell division.
The Recombinant Human GTPBP4 Protein is a 45-kDa protein consisting of 408 amino acids. It contains a conserved GTP-binding domain, which is essential for its function. The protein also has a C-terminal domain that is responsible for its interaction with other proteins. The crystal structure of the GTPBP4 protein has been determined, revealing its unique structure and providing insights into its function.
The main activity of Recombinant Human GTPBP4 Protein is its ability to bind to and hydrolyze GTP, a process that is essential for regulating the activity of GTPases. GTPBP4 is known to interact with several GTPases, including elongation factor G and translation initiation factor eIF5B. By interacting with these GTPases, GTPBP4 plays a crucial role in protein synthesis and cell growth.
Moreover, studies have shown that GTPBP4 is involved in the regulation of mitochondrial function. It has been found to interact with mitochondrial ribosomes and regulate their activity, thus playing a crucial role in mitochondrial protein synthesis. This protein has also been linked to the regulation of mitochondrial DNA replication and maintenance.
Recombinant Human GTPBP4 Protein has various applications in both research and medical fields. Its role in regulating GTPases makes it a valuable tool for studying cellular processes such as cell signaling and protein synthesis. Furthermore, its involvement in mitochondrial function makes it a potential target for the development of therapeutic interventions for mitochondrial diseases.
One of the major applications of Recombinant Human GTPBP4 Protein is in the field of cancer research. GTPBP4 has been found to be overexpressed in several types of cancer, including breast cancer and colorectal cancer. This overexpression has been linked to tumor growth and progression, making GTPBP4 a potential therapeutic target for cancer treatment.
In addition, Recombinant Human GTPBP4 Protein has been used in the development of diagnostic tools for various diseases. For instance, it has been used as an antigen in immunoassays to detect the presence of GTPBP4 antibodies in patients with autoimmune diseases such as systemic lupus erythematosus. This protein has also been used in the development of diagnostic tests for mitochondrial diseases.
In conclusion, Recombinant Human GTPBP4 Protein is a crucial protein involved in the regulation of GTPases and mitochondrial function. Its unique structure and activity make it a valuable tool for studying cellular processes and potential target for therapeutic interventions. Its diverse applications in research and medical fields make it a promising protein for further studies and developments.
ProteoGenix catalogue number ARO-P12132. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 42.87 kDa; Fragment: Met1-Gly350; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
